標(biāo)題: Titlebook: Novel Technologies for Vaccine Development; Igor S Lukashevich,Haval Shirwan Book 2014 Springer-Verlag Wien 2014 infectious disease.preven [打印本頁] 作者: Scuttle 時(shí)間: 2025-3-21 19:15
書目名稱Novel Technologies for Vaccine Development影響因子(影響力)
書目名稱Novel Technologies for Vaccine Development影響因子(影響力)學(xué)科排名
書目名稱Novel Technologies for Vaccine Development網(wǎng)絡(luò)公開度
書目名稱Novel Technologies for Vaccine Development網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Novel Technologies for Vaccine Development被引頻次
書目名稱Novel Technologies for Vaccine Development被引頻次學(xué)科排名
書目名稱Novel Technologies for Vaccine Development年度引用
書目名稱Novel Technologies for Vaccine Development年度引用學(xué)科排名
書目名稱Novel Technologies for Vaccine Development讀者反饋
書目名稱Novel Technologies for Vaccine Development讀者反饋學(xué)科排名
作者: 名義上 時(shí)間: 2025-3-21 21:25
Rajesh K. Sharma,Abhishek K. Srivastava,Hong Zhao,Esma S. Yolcu,Haval Shirwan作者: frozen-shoulder 時(shí)間: 2025-3-22 01:16 作者: 障礙 時(shí)間: 2025-3-22 05:40
Reverse Genetics Approaches for Rational Design of Inactivated and Live Attenuated Influenza Vaccine of influenza viruses from cloned cDNA, which allows the introduction of mutations at will. This technology has been used extensively to develop novel live attenuated vaccine candidates that possess attenuating mutations in one or several viral proteins, elicit cross-protective antibodies, and repli作者: justify 時(shí)間: 2025-3-22 10:24
Viral-Vectored Vaccines to Control Pathogenic Filovirusestive viral-vectored vaccines that have demonstrated efficacy in nonhuman primate models of filoviral hemorrhagic fever, two candidates, one based on a replication-defective adenovirus serotype 5 and the other on a recombinant vesicular stomatitis virus (rVSV), were shown to confer complete protectio作者: Blasphemy 時(shí)間: 2025-3-22 15:50 作者: 藝術(shù) 時(shí)間: 2025-3-22 19:23
Current Status and Future of Polio Vaccines and Vaccination interruption of virus circulation, vaccination against poliomyelitis will have to continue into the foreseeable future, due to significant differences in the nature and epidemiology of the viruses. This chapter reviews the reasons for the need to maintain high population immunity against poliovirus作者: Extemporize 時(shí)間: 2025-3-22 23:49
Experimental DNA-Launched Live-Attenuated Vaccines Against Infections Caused by Flavi- and Alphaviruion, especially for RNA viruses..Here we describe a novel infectious DNA (iDNA.) vaccine technology which combines advantages of naked DNA vaccination and live-attenuated vaccine efficacy. Using yellow fever 17D vaccine, an experimental IND vaccine TC-83 against Venezuelan equine encephalitis virus 作者: 營養(yǎng) 時(shí)間: 2025-3-23 03:00 作者: 陳腐的人 時(shí)間: 2025-3-23 05:48 作者: 連累 時(shí)間: 2025-3-23 10:08
Radiovirotherapy for the Treatment of Cancercation-competent oncolytic vectors is described, and this recognises the increasing acceptance of replicating viruses as the vectors of choice for cytotoxic gene therapy strategies. The section on oncolytic NIS-expressing viruses deals mainly with vectors based on adenovirus and measles virus. The f作者: 畸形 時(shí)間: 2025-3-23 15:36 作者: defendant 時(shí)間: 2025-3-23 19:12 作者: 猛然一拉 時(shí)間: 2025-3-24 01:46 作者: Decibel 時(shí)間: 2025-3-24 03:32 作者: Optimum 時(shí)間: 2025-3-24 06:30
Evgeniy A. Tkachenko,Tamara K. Dzagurova,Peter E. Tkachenkore there is little knowledge of the mechanisms of the changeover. The specific characteristics of the retail trade as well as the savings and investment patterns may create particular problems for Italy in connection with the changeover.作者: 圓木可阻礙 時(shí)間: 2025-3-24 14:03 作者: 感情 時(shí)間: 2025-3-24 17:18
e of the Euro-Atlantic security system, while the second part illustrates the limited success of Euro-Atlantic collaboration, for example in combating terrorism. Lastly, the third part discusses the consequences of the crisis, such as the conflict in Ukraine, and prospects for the future evolution o作者: 人類學(xué)家 時(shí)間: 2025-3-24 19:51 作者: atrophy 時(shí)間: 2025-3-25 00:30 作者: 鋼筆記下懲罰 時(shí)間: 2025-3-25 03:50
978-3-7091-1980-8Springer-Verlag Wien 2014作者: Hormones 時(shí)間: 2025-3-25 09:09 作者: 刪除 時(shí)間: 2025-3-25 15:16 作者: 有毒 時(shí)間: 2025-3-25 16:00 作者: 男生如果明白 時(shí)間: 2025-3-25 23:26 作者: Juvenile 時(shí)間: 2025-3-26 01:31
Viral-Vectored Vaccines to Control Pathogenic Filovirusesften fatal disease in humans and nonhuman primates. Pathogenic Marburg and Ebola viruses are endemic in resource-poor regions in Central Africa and are also of concern as they have the potential for deliberate misuse. Although no vaccines or antiviral drugs for filoviruses are currently available fo作者: 轉(zhuǎn)換 時(shí)間: 2025-3-26 05:44
Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Interventionce of an alphaviral structural polyprotein. Because viral structural genes are missing, replicon RNA cannot initiate replication of an alphavirus. However, due to the presence of intrinsic RNA-dependent RNA polymerase activity, replicons are capable of self-amplification in vitro and in vivo resulti作者: 代理人 時(shí)間: 2025-3-26 10:58 作者: 希望 時(shí)間: 2025-3-26 13:12
Current Status of Hantavirus Vaccines Developmentn the Americas. These viruses are carried by persistently infected rodents and are transmitted to humans by aerosolized rodent excreta. The number of reported cases of hantavirus infection is growing in many countries. New hantavirus strains have been increasingly isolated worldwide raising public-h作者: 加劇 時(shí)間: 2025-3-26 18:07 作者: Exonerate 時(shí)間: 2025-3-27 00:48
Sugar-Based Immune Adjuvants for Use in Recombinant, Viral Vector, DNA and Other Styles of Vaccines to find the best way to address this problem. A convenient solution is to identify a suitable adjuvant to add to the vaccine formulation to enhance its immunogenicity. Adjuvants come in many shapes and flavours, with no single unifying theme to explain why such a diversity of compounds should share作者: 修改 時(shí)間: 2025-3-27 05:06
Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccinestments to prevent or reduce the burdens of already developed diseases. This is achieved by means of activating various components of the immune system to generate systemic inflammatory reactions targeting infectious agents or diseased cells for control/elimination. DNA virus-based genetic vaccines g作者: CHOKE 時(shí)間: 2025-3-27 08:45
Radiovirotherapy for the Treatment of Cancere of radioisotopes into cancer cells for both detection and antitumor efficacy”. Having said that, it also addresses issues relating to combinations of virotherapy and standard anticancer modalities (such as external beam radiotherapy and cytotoxic chemotherapy) and novel agents (such as molecular r作者: 挖掘 時(shí)間: 2025-3-27 12:39 作者: Palate 時(shí)間: 2025-3-27 15:19
The Use of Oncolytic Herpesvirus for the Treatment of Canceriruses selectively replicate in tumor cells and may induce systemic antitumor immune responses. To date, the herpesviruses have been the most widely evaluated for clinical development as a cancer therapeutic. A modified herpesvirus encoding human granulocyte-macrophage colony-stimulating factor (GM-作者: 騙子 時(shí)間: 2025-3-27 18:41
SA-4-1BBL: A Novel Form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Developmenhe clinic, however, has been challenging. Although there are many factors impacting the efficacy of vaccines in humans, the most important ones are the prolonged tumor development and progression, altered immune responses due to extensive exposure to environmental pathogens, stage of cancer, standar作者: Fraudulent 時(shí)間: 2025-3-27 23:54
. By highlighting the causes, manifestations and international consequences of this evolution, the author describes a stage of crisis in the security system, characterized by increasing rivalry for spheres of influence, militarization of policies and the suspension of cooperation due to the growing 作者: FOLLY 時(shí)間: 2025-3-28 05:32
. By highlighting the causes, manifestations and international consequences of this evolution, the author describes a stage of crisis in the security system, characterized by increasing rivalry for spheres of influence, militarization of policies and the suspension of cooperation due to the growing 作者: clarify 時(shí)間: 2025-3-28 07:56 作者: 慎重 時(shí)間: 2025-3-28 12:02
Konstantin Chumakoval crisis of modern Europe is sketched, and the concept of the “dense society” is used to describe an expanding society with restricted mobility, limited vitality and excessive focus on the present. The special relation between society and finance is also amplified. Against this background, it is ma作者: 小母馬 時(shí)間: 2025-3-28 17:01
Evgeniy A. Tkachenko,Tamara K. Dzagurova,Peter E. Tkachenkoal crisis of modern Europe is sketched, and the concept of the “dense society” is used to describe an expanding society with restricted mobility, limited vitality and excessive focus on the present. The special relation between society and finance is also amplified. Against this background, it is ma作者: 同義聯(lián)想法 時(shí)間: 2025-3-28 19:17
Peter Pushko,Peter P. Bredenbeek,Igor S. Lukashevichstablished, and traces work accomplished on the system over the years through to the major developments of recent years. At the time of the first meeting in Rotterdam in 1987, a considerable number of generic or multi-attribute health status measures had been developed. Very few of these provided a 作者: 男學(xué)院 時(shí)間: 2025-3-29 02:11 作者: 不法行為 時(shí)間: 2025-3-29 04:31
The Use of Oncolytic Herpesvirus for the Treatment of Cancerd melanoma. This chapter will review the basic mechanisms of oncolytic viruses, describe the basic biology of herpesviruses, and discuss the clinical results of trials with T-VEC. Future directions and priorities for clinical development of T-VEC and other oncolytic viruses will be discussed.作者: conflate 時(shí)間: 2025-3-29 09:21
ector vaccines ?with focus on different cases of vaccine devThis book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines 作者: 倔強(qiáng)一點(diǎn) 時(shí)間: 2025-3-29 12:32 作者: 野蠻 時(shí)間: 2025-3-29 16:40 作者: 分期付款 時(shí)間: 2025-3-29 21:12 作者: ALLAY 時(shí)間: 2025-3-30 01:18 作者: Deference 時(shí)間: 2025-3-30 05:34
Keeping the Flow: Creating Opportunities Based on Well Structured Collaborationrs describe a well-structured mix of methods and instruments introducing “Cooperative Management-Systems”, the “CS-Procedure” and the “Heartbeat-Model”. This way, a complex and ambiguous environment is not just a threat to organisations but a playground for opportunities.
